Nov 17O7.57H7.79L7.34C7.58Vol4.692M
Absci Corp stock is traded at $7.58, with a volume of 4,691,750. It is up +1.40% in the last 24 hours and down -8.12% over the past month. Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
Previous Close:
$7.48
Open:
$7.57
24h Volume:
4,691,750
Relative Volume:
0.95
Market Cap:
$1.31B
Revenue:
$1.84M
Net Income/Loss:
-$118.44M
P/E Ratio:
-
EPS:
-$0.8291
Net Cash Flow:
-$98.51M
1W Performance:
-23.97%
1M Performance:
-8.12%
6M Performance:
+47.76%
1Y Performance:
+165.03%
1-Day Range:
$7.34$7.79
1-Week Range:
$7.29$10.50
52-Week Range:
$2.24$12.54
Absci Corp Stock (ABSI) Company Profile
Name
Absci CorpSector
HealthcareIndustry
BiotechnologyPhone
(360) 949-1041Address
18105 SE MILL PLAIN BLVD, VANCOUVER, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS